Valion Bio Inc(VBIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VBIO Valion Bio Inc

Trading 09-02 12:26:36 EDT

2.93

-0.14

-4.56%

High3.07	Low2.70	Vol78.23K
Open3.02	D1 Closing3.07	Amplitude11.90%
Mkt Cap2.60M	Tradable Cap2.59M	Total Shares887.59K
T/O227.74K	T/O Rate8.84%	Tradable Shares884.65K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VBIO","market":"US","secType":"STK","nameCN":"Valion Bio Inc","latestPrice":2.93,"timestamp":1788366388276,"preClose":3.07,"halted":0,"volume":78229,"delay":0,"changeRate":-0.04560260586319208,"floatShares":884654,"shares":887589,"eps":-210.1984,"marketStatus":"Trading","change":-0.14,"latestTime":"09-02 12:26:36 EDT","open":3.02,"high":3.0699,"low":2.7045,"amount":227742.768128,"amplitude":0.119023,"askPrice":2.93,"askSize":358,"bidPrice":2.8,"bidSize":340,"shortable":0,"etf":0,"ttmEps":-210.1984,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"listingDate":1636606800000,"exchange":"NASDAQ","adjPreClose":3.07,"preHourTrading":{"tag":"盘前","latestPrice":2.99,"preClose":3.07,"latestTime":"09:29 EDT","volume":5398,"amount":15910.494341,"timestamp":1788355799057,"change":-0.08,"changeRate":-0.026059,"amplitude":0.072345},"postHourTrading":{"tag":"盘后","latestPrice":2.94,"preClose":3.07,"latestTime":"19:59 EDT","volume":18254,"amount":53959.7823,"timestamp":1788307192635,"change":-0.13,"changeRate":-0.042345,"amplitude":0.112052},"volumeRatio":0.442542},"requestUrl":"/m/hq/s/VBIO/wiki","defaultTab":"wiki","newsList":[{"id":"2664885672","title":"Valion Bio Inc: Lisa Wolf Appointed as President & Chief Operating Officer; to Continue to Serve as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885672","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885672?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:08","pubTimestamp":1788264539,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T0HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664300038","title":"Valion Bio Names CFO Lisa Wolf President, COO After CEO Handley Exits","url":"https://stock-news.laohu8.com/highlight/detail?id=2664300038","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664300038?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:09","pubTimestamp":1788257356,"startTime":"0","endTime":"0","summary":"Valion Bio names CFO Lisa Wolf president, COO after CEO Handley exitsValion Bio appointed CFO Lisa Wolf as president and COO, taking executive leadership following former CEO Michael K. Handley’s depa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDLbpTSS5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663871019","title":"Valion Bio Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2663871019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663871019?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:50","pubTimestamp":1787961014,"startTime":"0","endTime":"0","summary":"19:50 EDT Valion Bio (VBIO) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valion-bio-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valion-bio-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707915","title":"Valion Bio - 1-for-25 Reverse Stock Split, Become Effective on August 31 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707915","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662707915?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:33","pubTimestamp":1787833989,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707666","title":"Valion Bio Announces 1-for-25 Reverse Stock Split Effective Aug. 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707666","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662707666?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:30","pubTimestamp":1787833845,"startTime":"0","endTime":"0","summary":"Valion Bio announces 1-for-25 reverse stock split effective Aug. 31Valion Bio set a 1-for-25 reverse stock split, effective Aug. 31 at 12:01 a.m. ET.Shares expected to trade split-adjusted at the open","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL9z6cwd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232321","title":"Valion Bio Amends 8-K to Report Final Vote Tally on Reverse Stock Split Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232321","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232321?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:16","pubTimestamp":1787256978,"startTime":"0","endTime":"0","summary":"Valion Bio amends 8-K to report final vote tally on reverse stock split approvalValion Bio filed an amended 8-K to replace preliminary vote tallies with final results from its Aug. 14, 2026 special me","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL6tdpH8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660481304","title":"Valion Bio Agrees to Sell 1,500 Series B Preferred Shares to 3i for $1.5 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660481304","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660481304?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:26","pubTimestamp":1786962407,"startTime":"0","endTime":"0","summary":"Valion Bio agrees to sell 1,500 Series B preferred shares to 3i for $1.5 million in private placementValion Bio entered a $1.5 million private placement with 3i, LP, issuing 1,500 Series B Non-Voting ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2xxr71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489791","title":"Valion Bio - Michael K. Handley Terminated as Chief Executive Officer, Effective August 16 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489791?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:12","pubTimestamp":1786961545,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E0GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659541124","title":"Valion Bio Q2 Net Loss Widens to $7.1 Million; Operating Loss Deepens to $6.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659541124","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659541124?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:34","pubTimestamp":1786743242,"startTime":"0","endTime":"0","summary":"Valion Bio Q2 net loss widens to $7.1 million; operating loss deepens to $6.4 millionValion Bio posted a GAAP net loss of $7.1 million for Q2 2026, widening from $1.93 million a year earlier.GAAP oper","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL5gktBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659688351","title":"Ukraine Health Ministry Starts Technical Assessment of Valion Bio’s Entolimod Dossier","url":"https://stock-news.laohu8.com/highlight/detail?id=2659688351","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659688351?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:00","pubTimestamp":1786629618,"startTime":"0","endTime":"0","summary":"Ukraine health ministry starts technical assessment of Valion Bio’s Entolimod dossierUkraine’s Ministry of Health accepted Valion Bio’s Entolimod dossier for formal review on July 22, 2026.Technical a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1S7tbv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659159403","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2659159403","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659159403?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:30","pubTimestamp":1786620654,"startTime":"0","endTime":"0","summary":"Leslie's (LESL) shares were down more than 42% premarket Thursday following the company's fiscal Q3 financial results.Valion Bio (VBIO) stock was 30% lower, continuing from a 27% fall in the prior ses","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NCPL","BK4135","BK4139","BK4129","BK4082","LESL","BK4200","OTLK","VBIO","FGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658890662","title":"Valion Bio Says U.S.-Funded Entolimod Safety Study for Radiation-Induced GI Injury Starts This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2658890662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658890662?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:23","pubTimestamp":1786548204,"startTime":"0","endTime":"0","summary":"Valion Bio says U.S.-funded Entolimod safety study for radiation-induced GI injury starts this weekValion Bio disclosed a U.S. government-funded AFRRI/NIAID program testing Entolimod for lethal radiat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL77sszd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658290895","title":"NASDAQ Trade Halt Volatility Trading Pause at 09:35 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2658290895","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658290895?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:35","pubTimestamp":1786541720,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 09:35 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nAQN2MEA1A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657366395","title":"Valion Bio Issues 1,287 Series a Preferred Shares in Unregistered Sale Tied to $750,000 Milestone Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657366395","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657366395?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:51","pubTimestamp":1786049464,"startTime":"0","endTime":"0","summary":"Valion Bio issues 1,287 Series A preferred shares in unregistered sale tied to $750,000 milestone paymentValion Bio issued 1,287 shares of Series A Preferred Stock in an unregistered sale to Statera Biopharma and Avenue Venture Opportunities Fund.Issuance dated July 31, 2026. Securities served as consideration for a $750,000 milestone payment tied to inventory validation for distribution and sales.Shares were sold in a private placement exemption under Section 4 and/or Regulation D. Securities are restricted under Rule 144.Company committed to file a resale registration statement within 60 days for common stock underlying the Series A Preferred Stock.Conversion is capped. Holders cannot exceed a beneficial ownership limit set between 4.9% and 19.9%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL4x5jwb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4082","STAB","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656137392","title":"3I, Lp Reports 9.9% Stake in Valion Bio Inc as of July 28 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2656137392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656137392?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:03","pubTimestamp":1785754998,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44018M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653757314","title":"Ukraine Health Ministry Accepts Valion Bio Entolimod Dossier for Regulatory Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757314","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757314?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:45","pubTimestamp":1784720719,"startTime":"0","endTime":"0","summary":"Ukraine health ministry accepts Valion Bio Entolimod dossier for regulatory reviewUkraine’s Ministry of Health accepted Valion Bio’s Entolimod dossier for formal review under its regulatory equivalenc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL7NrnTD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653975736","title":"Ukraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2653975736","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653975736?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:45","pubTimestamp":1784720712,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653395757","title":"Valion Bio - Formal Review of Entolimod in Ukraine May be Completed in 45 to 60 Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2653395757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653395757?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:45","pubTimestamp":1784720712,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0CO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653106812","title":"Valion Bio Notifies Availability of Press Release on Entolimod Trial at Sheba Medical Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2653106812","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653106812?lang=en_us&edition=fundamental","pubTime":"2026-07-21 01:29","pubTimestamp":1784568568,"startTime":"0","endTime":"0","summary":"Valion Bio notifies availability of press release on Entolimod trial at Sheba Medical CenterValion Bio disclosed a Sheba Medical Center-funded clinical trial to test Entolimod in cancer patients recei","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL16tvnB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105134","title":"Valion Bio Advances Entolimod Program with Government Engagement, Manufacturing Scale-Up, Oncology Supportive Care Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105134","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105134?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:35","pubTimestamp":1784032526,"startTime":"0","endTime":"0","summary":"Valion Bio  said Tuesday that it has advanced its Entolimod program through expanded US government engagement, a 200-fold manufacturing scale-up and plans to enter oncology supportive care.The company said it continues discussions with BARDA, NIAID, AFRRI and the Department of Defense on Acute Radiation Syndrome preparedness, while also engaging with Ukraine on potential stockpiling.Valion Bio said its unit, Velocity Bioworks, has completed a 200-fold manufacturing scale-up of Entolimod, equivalent to 1.3 million potential doses.The company said it also plans physician-sponsored studies evaluating Entolimod for chemotherapy-related neutropenia.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VBIO","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://valionbio.com","stockEarnings":[{"period":"1week","weight":-0.2277},{"period":"1month","weight":-0.6039},{"period":"3month","weight":-0.8096},{"period":"6month","weight":-0.8482},{"period":"1year","weight":-0.9603},{"period":"ytd","weight":-0.9153}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.01},{"period":"6month","weight":0.1181},{"period":"1year","weight":0.181},{"period":"ytd","weight":0.1171}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.211447},{"month":2,"riseRate":0.4,"avgChangeRate":-0.075585},{"month":3,"riseRate":0.4,"avgChangeRate":-0.163967},{"month":4,"riseRate":0.4,"avgChangeRate":0.102785},{"month":5,"riseRate":0.2,"avgChangeRate":-0.197414},{"month":6,"riseRate":0.4,"avgChangeRate":-0.04817},{"month":7,"riseRate":0.4,"avgChangeRate":-0.106505},{"month":8,"riseRate":0,"avgChangeRate":-0.340026},{"month":9,"riseRate":0,"avgChangeRate":-0.196548},{"month":10,"riseRate":0.5,"avgChangeRate":-0.035466},{"month":11,"riseRate":0.25,"avgChangeRate":0.035875},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08786}],"exchange":"NASDAQ","name":"Valion Bio Inc","nameEN":"Valion Bio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Valion Bio Inc(VBIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Valion Bio Inc(VBIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Valion Bio Inc,VBIO,Valion Bio Inc股票,Valion Bio Inc股票老虎,Valion Bio Inc股票老虎国际,Valion Bio Inc行情,Valion Bio Inc股票行情,Valion Bio Inc股价,Valion Bio Inc股市,Valion Bio Inc股票价格,Valion Bio Inc股票交易,Valion Bio Inc股票购买,Valion Bio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Valion Bio Inc(VBIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Valion Bio Inc(VBIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}